Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Tissue Engineering - Part C: Methods is Scopus-indexed (Q1, CiteScore 5), WoS SCIE. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1937-3384Verify ISSN ↗1937-3392Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 115 / 466 | 75th | Q1 |
| Biomedical Engineering | 153 / 342 | 55th | Q2 |
| Bioengineering | 95 / 168 | 43rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 5.
Tissue Engineering - Part C: Methods is Q1 in Medicine (miscellaneous) (rank 115 of 466), Q2 in Biomedical Engineering (rank 153 of 342) and Q3 in Bioengineering (rank 95 of 168), by CiteScore 2025.
Tissue Engineering - Part C: Methods is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.542, quartile Q2, with an H-index of 94.
Tissue Engineering - Part C: Methods is published by SAGE Publications Ltd. Its print ISSN is 1937-3384 and its online ISSN is 1937-3392.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Tissue Engineering - Part C: Methods has an h-index of 105 and a 2-year mean of 1.93 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q1. On 2-year citations it ranks #170 of 451 Scopus journals in Medicine (miscellaneous).
Tissue Engineering - Part C: Methods published 42 papers in 2025; its busiest recent year was 2017 with 106. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from United States (28.8%), China (26.8%) and Netherlands (6.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.